Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Insulin Resistance Atherosclerosis Study (IRAS)

This study has been completed.
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI) Identifier:
First received: May 25, 2000
Last updated: August 5, 2016
Last verified: April 2009
To conduct a multicenter study of the relationship between insulin resistance and cardiovascular disease (CVD) and its risk factors in a tri-ethnic (African-American, Hispanic, and non-Hispanic white) population aged 40 to 69 years at baseline. Also, to identify the genetic determinants of insulin resistance and visceral adiposity.

Cardiovascular Diseases
Diabetes Mellitus
Heart Diseases
Insulin Resistance

Study Type: Observational

Resource links provided by NLM:

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: September 1991
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Show Detailed Description


Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00005135

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
OverallOfficial: Richard Bergman University of Southern California
OverallOfficial: Donald Bowden Wake Forest University
OverallOfficial: Michael Bryer-Ash University of California, Los Angeles
OverallOfficial: Steven Haffner University of Texas
OverallOfficial: Jill Norris University of Colorado, Denver
OverallOfficial: Marian Rewers University of Colorado Health Science Center
OverallOfficial: Mohammed Saad University of Southern California
OverallOfficial: Joseph Selby Kaiser Foundation Research Institute
OverallOfficial: Lynne Wagenknecht Wake Forest University
  More Information

Publications: Identifier: NCT00005135     History of Changes
Other Study ID Numbers: 1005  U01HL047890 
Study First Received: May 25, 2000
Last Updated: August 5, 2016
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Insulin Resistance
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Arterial Occlusive Diseases
Vascular Diseases processed this record on October 28, 2016